Highlights NEXTURNBIOSCIENCE Co., Ltd.

Equities

A089140

KR7089140008

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-06-06 pm EDT			5-day change	1st Jan Change
3,615 ^KRW	+0.70%		-0.69%	-34.51%

Mar. 21	NEXTURNBIOSCIENCE Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	NEXTURNBIOSCIENCE Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

NEXTURNBIOSCIENCE Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 20	CI
NEXTURNBIOSCIENCE Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13	CI
NEXTURNBIOSCIENCE Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-11	CI
NEXTURNBIOSCIENCE Co., Ltd. completed the acquisition of 10.59% stake in Mirae Corporation from KANGLIM Co., Ltd.	23-07-11	CI
NEXTURNBIOSCIENCE Co., Ltd. agreed to acquire a 10.59% stake in Mirae Corporation from KANGLIM Co., Ltd.	23-05-22	CI
NEXTURNBIOSCIENCE Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-09	CI
NEXTURNBIOSCIENCE Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-21	CI
NEXTURNBIOSCIENCE Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
NEXTURNBIOSCIENCE Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-12	CI
NEXTURNBIOSCIENCE Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-16	CI
NEXTURNBIOSCIENCE Co., Ltd. agreed to acquire a 78.9% stake in Roll Korea Co., Ltd. from Ma Su Ran and Kim Jong Kyu for KRW 13.4 billion.	22-05-12	CI
NEXTURNBIOSCIENCE Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-15	CI
Kingdom Ut 1 Association, Joo-Yong Choi, Kim, Mi-ryeong, Kim, Mi-hye, Seunghee Lee and Kim, Hye-sook agreed to acquire 5.4% stake in NexturnBioscience Co., Ltd in NexturnBioscience Co., Ltd from Studio Santa Claus Entertainment Co., Ltd. for KRW 12.5 million.	21-10-28	CI
NexturnBioscience Co., Ltd acquired 8.83% stake in EV Advanced Material Co.,Ltd from SL Vionics Co., Ltd. for approximately KRW 13 billion.	21-07-20	CI
Studio Santa Claus Entertainment Co., Ltd. acquired an additional 5.7% minority stake in NexturnBioscience Co., Ltd from pacing, Sohn Young-sook, Peng Mi-sun and Shin Ji-yoon for KRW 9.8 billion.	21-06-20	CI
Nexturn Bio Inc. Decides to Invest in the Development of A New Drug Pipeline for Diabetes Treatment Using Mirna	21-05-06	CI
Studio Santa Claus Entertainment Co., Ltd. completed the acquisition of 41.4% stake in Nexturn Co.,Ltd. from Daeho Technology Korea Co., Ltd. and Wooa Corporation.	21-03-22	CI
Studio Santa Claus Entertainment Co., Ltd. intends to acquire 41.4% stake in Nexturn Co.,Ltd. from Daeho Technology Korea Co., Ltd. and Wooa Corporation for KRW 70 billion.	20-12-28	CI
Nexturn Co.,Ltd. cancelled the acquisition of 2.4% stake in Ryukil C&S Co., Ltd..	18-05-28	CI
Nexturn Co.,Ltd.'s Equity Buyback announced on October 30, 2017 has expired.	18-04-29	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights NEXTURNBIOSCIENCE Co., Ltd.

Equities

A089140

KR7089140008

Highlights

Filters